Langerhans cell histiocytosis of the maxillae in a child treated only with chemotherapy: a case report (Q41896408)

13 October 2017

0 references

Langerhans cell histiocytosis of the maxillae in a child treated only with chemotherapy: a case report (English)

1 reference

Langerhans cell histiocytosis specific to childhood

13 October 2017

1 reference

Angela Pia Cazzolla

1

0 references

Giuseppe Troiano

Giuseppe Troiano

2

0 references

Franca Dicuonzo

Franca Dicuonzo

8

0 references

Lorenzo Lo Muzio

Lorenzo Lo Muzio

10

0 references

Khrystyna Zhurakivska

3

Khrystyna Zhurakivska

1 reference

13 October 2017

5

Gianfranco Favia

1 reference

13 October 2017

6

Maria Grazia Lacaita

1 reference

13 October 2017

Eugenio Maiorano

4

1 reference

13 October 2017

Giuseppe Marzo

7

1 reference

13 October 2017

Stefano Andresciani

9

1 reference

13 October 2017

language of work or name

English

0 references

publication date

9 May 2017

1 reference

Journal of Medical Case Reports

13 October 2017

1 reference

13 October 2017

11

1 reference

13 October 2017

1

1 reference

13 October 2017

130

1 reference

Langerhans cell histiocytosis in children: from the bench to bedside for an updated therapy

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Langerhans Cell Histiocytosis Treatment (PDQ®): Health Professional Version

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Pathogenesis of Langerhans cell histiocytosis.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Recent advances in the understanding of Langerhans cell histiocytosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Ontogeny and homeostasis of Langerhans cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Langerhans cell histiocytosis: literature review and descriptive analysis of oral manifestations.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Expansion of regulatory T cells in patients with Langerhans cell histiocytosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Steady-state and inflammatory dendritic-cell development

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Biology of Langerhans cells and Langerhans cell histiocytosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Dendritic cells: translating innate to adaptive immunity.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Drug therapy for the treatment of Langerhans cell histiocytosis.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

CD1a and langerin: acting as more than Langerhans cell markers

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Oral manifestations of Langerhans cell histiocytosis. Case study of a two-year-old boy.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Langerhans' cell histiocytosis restricted to the oral mucosa

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Histiocytosis X cells in eosinophilic granuloma express Ia and T6 antigens

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Histiocytosis-X: In Situ Characterization of Cutaneous Infiltrates with Monoclonal Antibodies

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Immunohistochemical study of idiopathic histiocytosis of the mandible and maxilla

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Defective alloantigen-presenting capacity of 'Langerhans cell histiocytosis cells'

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Vemurafenib Use in an Infant for High-Risk Langerhans Cell Histiocytosis.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

Langerhans-cell histiocytosis 'insight into DC biology'.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

A randomized trial of treatment for multisystem Langerhans' cell histiocytosis

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5422897

[Langerin: a new lectin specific for Langerhans cells induces the formation of Birbeck granules]

18 August 2018

1 reference

12 December 2020

Differentiation of Langerhans cells in Langerhans cell histiocytosis

1 reference

12 December 2020

Langerhans cell histiocytosis in an adult

1 reference

12 December 2020

Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosis

1 reference

12 December 2020

10.1186/S13256-017-1286-3

Identifiers

DOI

1 reference

Dimensions Publication ID

13 October 2017

0 references

1 reference

13 October 2017

PubMed publication ID

28482919

1 reference